FL S1336

Prohibits health insurers from requiring insureds to obtain prescription drugs for chronic illnesses (HIV infection, epilepsy, hypertension, or diabetes) exclusively from mail order pharmacies, unless the drug is an excluded drug subject to FDA restrictions or requiring special handling.

Prevents insurers and health maintenance organizations from imposing additional copayments or conditions on insureds who use retail pharmacies instead of mail order pharmacies if the retail pharmacy meets the same credentialing standards and accepts equivalent reimbursement rates.

Requires health insurers and HMOs to disclose in their outlines of coverage that insureds may obtain chronic illness prescription drugs from retail pharmacies and that exclusive mail order use is not required unless the drug is excluded.

Exempts grandfathered health plans and certain benefits specified in existing statutes from these requirements.

Takes effect January 1, 2018.